Literature DB >> 6951237

Septic arthritis due to Candida species on patients with cancer: report of five cases and review of the literature.

V Fainstein, C Gilmore, R L Hopfer, A Maksymiuk, G P Bodey.   

Abstract

In disseminated candidiasis, various organs frequently become involved, usually as a consequence of hematogenous spread of the organism. However, involvement of the joints is rare even with dissemination. Nineteen cases of joint involvement have previously been reported in adults and 21 cases in children. The most commonly involved joint has been the knee; in such cases, amphotericin B has been effective in controlling the infection. Five patients with cancer developed septic arthritis due to Candida species at the M. C. Anderson Hospital and Tumor Institute in the past five years. Four of these patients were seen in 1980. Candida albicans was isolated from three patients and Candida tropicalis from two. All five patients had predisposing conditions - e.g., intravenous and/or urinary catheterization, neutropenia, and previous treatment with steroids and antibiotics. The knee was the affected joint in all five. Different modalities of treatment were used, including intravenous miconazole, oral ketoconazole, and systemic and local amphotericin B; adequate levels of these drugs were found in the joint fluid when measured. Infection was cured in two patients. The condition of the third patient improved. The fourth patient died of disseminated disease despite therapy, and the fifth died of malignancy without the benefit of antifungal therapy. For treatment of such infections, the use of an antifungal agent is recommended in addition to frequent evacuation of the joint fluid. Some new compounds may prove useful alternatives to amphotericin B. Arthritis can be resolved even in the presence of unresolved disseminated disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6951237     DOI: 10.1093/clinids/4.1.78

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  9 in total

Review 1.  Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: case report and review of the literature.

Authors:  G Weers-Pothoff; J F Havermans; J Kamphuis; H A Sinnige; J F Meis
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

Review 2.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

3.  Transient fungemia and Candida arthritis due to Candida zeylanoides.

Authors:  J Bisbe; J Vilardell; M Valls; A Moreno; M Brancos; J Andreu
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

Review 4.  Candidiasis.

Authors:  F Meunier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

5.  An unusual case of Candida tropicalis and Candida krusei arthritis in a patient with acute myelogenous leukemia before chemotherapy.

Authors:  Hon-Pin Wang; Yung-Feng Yen; Wei-Sheng Chen; Yuh-Lan Chou; Chang-Youh Tsai; Hsiao-Ning Chang; Chung-Tei Chou
Journal:  Clin Rheumatol       Date:  2006-06-08       Impact factor: 2.980

6.  Candida infection of a prosthetic shoulder joint.

Authors:  E A Lichtman
Journal:  Skeletal Radiol       Date:  1983       Impact factor: 2.199

7.  Micro-CT analysis of experimental Candida osteoarthritis in rats.

Authors:  Takamasa Amanai; Yasunori Nakamura; Shigeji Aoki; Izumi Mataga
Journal:  Mycopathologia       Date:  2008-06-04       Impact factor: 2.574

8.  Candida tropicalis arthritis of the elbow in a patient with Ewing's sarcoma that successfully responded to itraconazole.

Authors:  Seung Youn Kim; Jung Sub Lim; Dong Hwan Kim; Hyeon Jeong Lee; Joong Bum Cho; Jun Ah Lee; Dong Ho Kim
Journal:  Korean J Pediatr       Date:  2011-09-30

9.  Candida Arthritis: Analysis of 112 Pediatric and Adult Cases.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Nikolaos V Sipsas; Brad Moriyama; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Saad J Taj-Aldeen; Andy O Miller; Ruta Petraitiene; Olivier Lortholary; Thomas J Walsh
Journal:  Open Forum Infect Dis       Date:  2015-12-23       Impact factor: 3.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.